Clinical Trial Update: Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical Dystonia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing short-term efficacy of Dysport and Dysport NG to placebo in cervical dystonia; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dystonia

Drugs mentioned

• Dysport (abobotulinumtoxinA)
• Dysport NG (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Cervical Dystonia | Phase 3 | Status: COMPLETED | Results posted: 2019-09-24